CKD-712

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCKD-712
Drug Alias NameCKD-712
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide synthase, inducible inhibitorsNuclear factor NF-kappa-B complex inhibitors
TargetsNuclear factor NF-kappa-B complexNitric oxide synthase, inducible
Therapy Area/IndicationsSepsis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active IndicationsSepsis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A